Afyren SAS

Trend Analysis of Afyren SAS

Momentum appears favorable in the short term, with a recent rebound that contrasts with a still very deteriorated long-term trend. For investors, this points to a speculative case in recovery mode, driven by the appeal of bio-based solutions, but whose market credibility will remain tied to the company’s ability to turn its technological potential into sustained operational traction.